Compare · SBRA vs VTR
SBRA vs VTR
Side-by-side comparison of Sabra Health Care REIT Inc. (SBRA) and Ventas Inc. (VTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SBRA and VTR operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- VTR is the larger of the two at $44.44B, about 8.8x SBRA ($5.03B).
- Over the past year, SBRA is up 6.0% and VTR is up 27.4% - VTR leads by 21.3 points.
- SBRA has been more active in the news (14 items in the past 4 weeks vs 3 for VTR).
- Both have 25 recent analyst ratings on file.
- Company
- Sabra Health Care REIT Inc.
- Ventas Inc.
- Price
- $19.78+0.51%
- $86.83+0.28%
- Market cap
- $5.03B
- $44.44B
- 1M return
- -5.04%
- -7.45%
- 1Y return
- +6.03%
- +27.36%
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 14
- 3
- Recent ratings
- 25
- 25
Sabra Health Care REIT Inc.
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
Ventas Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Latest SBRA
- Huntington initiated coverage on Sabra Health Care REIT with a new price target
- Chair, CEO and President Matros Richard K sold $4,166,000 worth of shares (200,000 units at $20.83) as part of a pre-agreed trading plan (SEC Form 4)
- Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference
- SEC Form 144 filed by Sabra Health Care REIT Inc.
- Executive VP, CIO & Secretary Smith Darrin was granted 495 shares, increasing direct ownership by 0.43% to 116,919 units (SEC Form 4)
- Director Malehorn Jeffrey A. was granted 791 shares, increasing direct ownership by 0.68% to 117,137 units (SEC Form 4)
- Director Katzmann Lynne S was granted 791 shares, increasing direct ownership by 0.92% to 86,912 units (SEC Form 4)
- Director Kono Ann was granted 791 shares, increasing direct ownership by 1% to 68,977 units (SEC Form 4)
- Director Foster Michael J was granted 791 shares, increasing direct ownership by 0.96% to 82,834 units (SEC Form 4)
- Director Cusack Catherine was granted 791 shares, increasing direct ownership by 0.96% to 82,847 units (SEC Form 4)
Latest VTR
- Ventas Inc. filed SEC Form 8-K: Leadership Update
- Jefferies resumed coverage on Ventas with a new price target
- Ventas Declares Quarterly Dividend of $0.52 Per Common Share
- Ventas Releases 2025-2026 Corporate Sustainability Report
- EVP OM&R-Ventas/Pres&CEO-LHS Wattula Andy was granted 15,008 shares (SEC Form 4)
- SEC Form 3 filed by new insider Wattula Andy
- SEC Form 10-Q filed by Ventas Inc.
- Ventas Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ventas Reports 2026 Second Quarter Results
- Amendment: SEC Form SCHEDULE 13G/A filed by Ventas Inc.